To access this course, you need to be logged in/registered. Click here to continue.

Oral aspects HIV & AIDS, massive haemorrhage in trauma, antibiotic resistance in developing countries

Expiry Date
: 01/04/2026
CPD Units
: 3.00 Points
Rating
: Not yet rated.

This article studies various clinical strategies that can be employed in pharmacology to support the development of oncology treatments via drug development and antibody–drug conjugates.

Keywords: Antibody–drug conjugate, Clinical pharmacology, Exposure–response analysis, Specific population, Drug interaction

Reading material:

Educational Objectives

Educational Aim:

The aim of this article is to understand the role and mechanisms of antibody–drug conjugates in cancer treatment.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

  1. Clinical pharmacology assessments for ADCs to address scientific and regulatory concerns.
  2. The mechanism of ADCs.
  3. The different ADCs currently on the market along with their benefits and limitations.

Instructions for this Module

  • Read the supplied reading material and complete the quiz that follows;
  • You have three attempts to pass the quiz;
  • The pass grade is 70%;
  • You need to pass the quiz to claim your CPD certificate;
  • Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us